BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 3, 2017
View Archived Issues
GlaxoSmithKline offers pipeline progress report for first quarter 2017
Read More
Rigel describes novel JAK inhibitors
Read More
Medeor obtains IND clearance and SPA agreement with the FDA for phase III trial of MDR-101
Read More
Tesaro submits IND for TSR-033
Read More
Sunesis to withdraw MAA for vosaroxin in AML
Read More
Concert Pharmaceuticals initiates phase II trial of CTP-543 in alopecia areata
Read More
Corvus expands CPI-444 collaboration with Genentech
Read More
FDA grants fast track designation to ALT-803 as treatment for non-muscle invasive bladder cancer
Read More
FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture
Read More
Sanofi presents first-in-human data for the humanized anti-CD52 antibody GLD-52
Read More
Pieris and AstraZeneca establish respiratory disease collaboration
Read More
ZED-1227 for celiac disease completes phase Ib study
Read More
Mutations in NFKBIA found to confer resistance to multiple sclerosis treatment with MIS-416
Read More
FDA accepts IND for phase II trial of GKT-831 in primary biliary cholangitis
Read More
Agency for Science, Technology and Research (A*STAR) patents SMYD3 inhibitors
Read More
NIAID grant supports Lyndra's development of ultra-long acting HIV therapy
Read More
Selecta licenses LMB-100 from National Cancer Institute
Read More
FDA approves Ventana PD-L1 Assay as companion diagnostic for Imfinzi
Read More
Abivax reports effect of ABX-464 on HIV blood reservoir in phase IIa study
Read More
Gruenenthal identifies Cav2.2 channel blockers
Read More
French researchers present azaphenantrene analogues
Read More
FDA grants regenerative medicine advanced therapy designation to jCell
Read More
Sosei obtains equity stake and option to acquire MiNA Therapeutics
Read More
